PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER AND OTHER INDICATIONS INDICATIONS
$375,416N01FY2024CANIH
Iit Research Institute, Chicago IL
Investigators
Abstract
The test agent is being considered for development of an anticancer therapeutic.
View original record on NIH RePORTER →